PDCD1 and melanoma: For instance, Li et al. (22) applied liquid chromatography (LC)-MS to measure changes in metabolite levels in serum from patients with melanoma and renal cell carcinoma before and after treatment with nivolumab and revealed that elevated kynurenine metabolism is associated with resistance to anti-PD-1 and decreased overall survival.